The University of Manchester Innovation Factory has launched four new University spinout companies into its growing portfolio, continuing a strong year of translating world-leading research into businesses with the potential to deliver real-world impact.
InformiX Pharma, C3 Biotechnologies, Precica and FLAG-Me SAFE have each reached important milestones in their commercialisation pathway, joining Grid Stability, Luteo Medical and SpinOr as University of Manchester spinouts created during the current financial year.
Working alongside academic founders throughout the commercialisation process, the Innovation Factory provides expertise in intellectual property and business strategy, business development, licensing, company formation and investment readiness, helping researchers navigate the journey from discovery to market.
The latest companies reflect the breadth of innovation emerging from The University of Manchester.
InformiX Pharma has developed specialist three-dimensional advanced imaging technology to give pharmaceutical companies un-precedented understanding into the internal structure of medicines, resulting in faster product development, improved product quality and more informed decision making.
C3 Biotechnologies is developing innovative microbial technologies that convert industrial waste streams, including carbon dioxide, into sustainable chemicals and high-value products, helping accelerate the transition to more sustainable industrial manufacturing.
Precica is helping organisations manage growing volumes of data through innovative technology that dramatically reduces storage requirements, allowing information to be searched and analysed without first unpacking it.
FLAG-Me SAFE has developed an innovative digital safeguarding platform that helps pharmacists and medical professionals identify individuals with a visual and other communication impairments earlier, supporting them with medication needs in a safe way.
Dr Catherine Headley, Chief Executive Officer of The University of Manchester Innovation Factory, said: "These four companies demonstrate the remarkable breadth of innovation emerging from The University of Manchester. From helping people manage their medication more safely, to enabling more sustainable manufacturing, and transforming the way organisations manage data, each has the potential to make a meaningful difference.
"Supporting researchers as they translate ideas into successful businesses, is what the Innovation Factory exists to do. We are proud to have worked alongside these talented founding teams throughout their commercialisation pathway, and we are excited to see how their innovations will benefit people, industry and communities around the world."
Alongside company formation, the Innovation Factory continues to work with researchers across the University to identify commercial opportunities and help innovations reach the people and industries that can benefit from them.
